NL8601519A - Furosemidezouten. - Google Patents

Furosemidezouten. Download PDF

Info

Publication number
NL8601519A
NL8601519A NL8601519A NL8601519A NL8601519A NL 8601519 A NL8601519 A NL 8601519A NL 8601519 A NL8601519 A NL 8601519A NL 8601519 A NL8601519 A NL 8601519A NL 8601519 A NL8601519 A NL 8601519A
Authority
NL
Netherlands
Prior art keywords
furosemide
quaternary ammonium
choline
compounds
reaction component
Prior art date
Application number
NL8601519A
Other languages
English (en)
Dutch (nl)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NL8601519A publication Critical patent/NL8601519A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
NL8601519A 1985-07-02 1986-06-11 Furosemidezouten. NL8601519A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/751,763 US4663348A (en) 1985-07-02 1985-07-02 Furosemide salts and pharmaceutical preparations thereof
US75176385 1985-07-02

Publications (1)

Publication Number Publication Date
NL8601519A true NL8601519A (nl) 1987-02-02

Family

ID=25023379

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8601519A NL8601519A (nl) 1985-07-02 1986-06-11 Furosemidezouten.

Country Status (14)

Country Link
US (1) US4663348A (fr)
JP (1) JPS625975A (fr)
AU (1) AU599034B2 (fr)
BE (1) BE904986A (fr)
CH (1) CH670448A5 (fr)
DE (1) DE3619665A1 (fr)
DK (1) DK312586A (fr)
FR (1) FR2584405B1 (fr)
GB (1) GB2189239B (fr)
IT (1) IT1191972B (fr)
LU (1) LU86484A1 (fr)
NL (1) NL8601519A (fr)
SE (1) SE8602917L (fr)
ZA (1) ZA864207B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920145A (en) * 1988-02-29 1990-04-24 Gaf Chemical Corporation Water-soluble complexes of water-insoluble pharmaceutical compounds and preparation thereof
IT1237115B (it) * 1989-10-24 1993-05-18 Sali della furosemide, procedimento per la loro preparazione e composizionni farmaceutiche che li contengono
DE69118716T2 (de) * 1991-12-03 1996-12-19 Kokuyo Kk Beidseitig zu öffnende/verschliessende vorrichtung zum ordnen
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
FI114538B (fi) * 2001-01-12 2004-11-15 Finnfeeds Finland Ltd Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
TWI555751B (zh) * 2010-02-10 2016-11-01 Kissei Pharmaceutical Condensed heterocyclic derivatives of the salt and its crystallization
EP3799869A1 (fr) 2013-04-05 2021-04-07 ScPharmaceuticals Inc. Formulations pharmaceutiques pour l'administration sous-cutanée de furosémide
CA3123718A1 (fr) 2019-01-04 2020-07-09 Sq Innovation Ag Compositions pharmaceutiques de furosemide et leurs utilisations
MX2021009084A (es) 2019-01-31 2021-10-26 Scpharmaceuticals Inc Formulaciones farmaceuticas liquidas concentradas de furosemida y metodos para administrar las mismas.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3565920A (en) * 1966-12-29 1971-02-23 Ciba Geigy Corp 5-sulfamyl-anthranilic acids
DK138322B (da) * 1970-07-13 1978-08-14 Dumex Ltd As Fremgangsmåde til fremstilling af N-substituered antranilsyrederivater.
FR2210607A1 (en) * 1972-12-20 1974-07-12 Aries Robert 4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid prepn. - from furfural and 4-chloro-5-sulphamoyl anthranilic acid
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets
LU74319A1 (fr) * 1976-02-09 1977-08-19
DE3025367A1 (de) * 1980-07-04 1982-01-28 Hoechst Ag, 6000 Frankfurt Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung

Also Published As

Publication number Publication date
SE8602917D0 (sv) 1986-07-01
SE8602917L (sv) 1987-01-03
AU599034B2 (en) 1990-07-12
IT1191972B (it) 1988-03-31
BE904986A (fr) 1986-12-24
US4663348A (en) 1987-05-05
LU86484A1 (fr) 1986-12-02
JPS625975A (ja) 1987-01-12
ZA864207B (en) 1987-02-25
IT8648183A0 (it) 1986-06-25
DK312586A (da) 1987-01-03
FR2584405B1 (fr) 1989-02-24
AU5889086A (en) 1987-01-08
CH670448A5 (fr) 1989-06-15
DE3619665A1 (de) 1987-01-08
GB2189239A (en) 1987-10-21
GB2189239B (en) 1989-02-01
DK312586D0 (da) 1986-07-01
FR2584405A1 (fr) 1987-01-09
GB8615275D0 (en) 1986-07-30

Similar Documents

Publication Publication Date Title
US4849425A (en) Readily absorbable pharmaceutical composition
NL8601519A (nl) Furosemidezouten.
JPS6191116A (ja) 安定化された注射用ピロキシカム液剤
JPH0460987B2 (fr)
SU1514240A3 (ru) СПОСОБ ПОЛУЧЕНИЯ СТАБИЛЬНЫХ ЦИКЛОДЕКСТРИН-РОМАШКОВЫХ КОМПЛЕКСОВ, включения
JPH0419996B2 (fr)
KR860001865B1 (ko) 2'-데옥시-5-치환 우리딘 유도체의 제조방법
KR840000702B1 (ko) 빈카민 사카리네이트의 제조방법
JPS6259264A (ja) ５−ピリミジンカルボキサミド、それらの製造法およびそれらからなる医薬組成物
CA1219582A (fr) Composes pharmaceutiques capables d'augmenter la concentration cerebrale de la serotonine
JP3076672B2 (ja) キノリン誘導体のフマル酸塩
EP0040422B1 (fr) Pyrazinyl-1,2,4-oxadiazoles, procédés pour leur préparation et préparations pharmaceutiques les contenant
US4698361A (en) Tris-chydroxymethyl) aminomethane salt of 4-chloro-N-furfuryl-5-sulfamoyl anthranilic acid and diuretic compositions containing the same
CA1065865A (fr) Sel de piperazinyluracil
JPH10507446A (ja) ビス−２−アミノピリジン類、その製造方法及び寄生虫感染を制御するためのその用途
PL138044B1 (en) Method of obtaining salts of ethylenediamine,ethanolamine or diethanolamine and n-/2-pyridil/-2-methyl-4-hydroxy-2h-1,2-benzothiazinocraboxyamide-3 1,1-dioxide
US4329355A (en) Mesoionic antitumor compositions and methods for using the same in the treatment of cancer
US4218465A (en) Glyoxylic acid hydrocarbylsulfonylhydrazones and therapeutic compositions
JPH0370700B2 (fr)
KR100256078B1 (ko) 2-아미노에탄술폰산 아연 착체(錯體)
CA1254569A (fr) Sels d'acide sulfonique et de 6-amino 1, 5-dihydro- 4h-imidazo¬4,5-c|pyridin-4-one
WO2005023803A1 (fr) Sel d'acide phosphorique de 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy]phenyl]methyl]-2,4-thiazolidinedione
JPH0340038B2 (fr)
US4761478A (en) 3-deazaguanine sulfonic acid salts
JP2000044584A (ja) アミノ酸誘導体・オキソバナジウム（ｉｖ）錯体